This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07891/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07891/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07891/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07891/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07891/identifier/pdb/

Statements

Subject Item
n2:DB07891
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB07891 n13:DB07891
dcterms:title
4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid
adms:identifier
n7:99444362 n10:HE7 n11:66440 n12:59813 n14:DB07891
n3:IUPAC-Name
n4:271B4976-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B497C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B497B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4978-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4979-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B497A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4974-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4975-363D-11E5-9242-09173F13E4C5 n4:271B4972-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4973-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4982-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4983-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B497D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B497E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4980-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B497F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4981-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4988-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B498A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B498B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4987-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4986-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4989-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4977-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4984-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4985-363D-11E5-9242-09173F13E4C5